Nalaganje...
Linezolid for drug‐resistant pulmonary tuberculosis
BACKGROUND: Linezolid was recently re‐classified as a Group A drug by the World Health Organization (WHO) for treatment of multi‐drug resistant tuberculosis (MDR‐TB) and extensively drug‐resistant tuberculosis (XDR‐TB), suggesting that it should be included in the regimen for all patients unless con...
Shranjeno v:
| izdano v: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley & Sons, Ltd
2019
|
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6426281/ https://ncbi.nlm.nih.gov/pubmed/30893466 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012836.pub2 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|